Clinical trial shows promise of immune treatment against HPV infections that lead to cancer
Nicole Fawcett is the manager of cancer communication for the University of Michigan Rogel Cancer Center, overseeing media relations, marketing, web, internal communication, social media and publications for the center’s research and clinical enterprises. She leads a team of four communicators who produce targeted, innovative communication to meet the Cancer Center’s goals. Nicole joined Michigan Medicine in 2003. Prior to that, she was at the Detroit News and at a startup web-based community for people with disabilities.
While it plays a protective role in other diseases, knocking out NLRP6 in mice led to better outcomes, less-severe symptoms after bone marrow transplant.
Exposure to chemotherapy can create hazards for nurses, pharmacists as they deliver lifesaving care to patients, but use of protective devices remains low.<
A genetic mutation makes a glioma subtype resistant to radiation, but a new study finds a potential way around it using currently available drugs.
Up to one-third of primary care providers discussed breast cancer treatment options with patients but many report gaps in their knowledge.
The stable structure of circRNA makes it an ideal candidate for biomarkers because it can be detected in blood or urine, making it potentially useful for cancer diagnosis or prognosis.